Ingevity Corporation
NGVTBasic MaterialsNASDAQSpecialty Chemicals · Last scanned Jun 2, 2026
Scan Results
Daily timeframePart of the basic materials sector, Ingevity Corporation (NGVT) is listed under Specialty Chemicals. The $2.31B market capitalization puts NGVT squarely in mid-cap range for its industry. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Market Cap
$2.31B
Beta
1.24
P/E (TTM)
—
P/E (Fwd)
11.56
EPS (TTM)
$-4.29
EPS (Fwd)
$5.75
ROE
-114.1%
ROA
9.0%
Cash
$95.4M
Total Debt
$1.24B
Free CF
$225.8M
52W Change
59.5%
Annual Financials
Cash vs Debt
On the balance sheet, NGVT has $95.4M in cash with $1.24B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $225.8M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -114.1% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 9.0% suggests reasonable efficiency in deploying the company's asset base. Revenue has pulled back from $1.67B (2022) to $1.17B (2025), a 30% decline worth watching.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. No single metric tells the full story. Reviewing NGVT's risk profile alongside its fundamentals and technical indicators provides a more complete picture.